申请人:C4 Therapeutics, Inc.
公开号:US11407732B1
公开(公告)日:2022-08-09
Tricyclic cereblon binders for the degradation of Ikaros or Aiolos by the ubiquitin proteasome pathway for therapeutic applications are described.
介绍了用于治疗的三环脑龙结合剂,可通过泛素蛋白酶体途径降解 Ikaros 或 Aiolos。